CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,668 | -10.8% | 213 | +10.4% | 0.00% | – |
| Q2 2023 | $10,835 | +24.1% | 193 | 0.0% | 0.00% | – |
| Q1 2023 | $8,729 | -10.5% | 193 | -19.6% | 0.00% | – |
| Q4 2022 | $9,756 | -53.5% | 240 | -23.6% | 0.00% | -100.0% |
| Q3 2022 | $21,000 | +10.5% | 314 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | 0.0% | 317 | +4.3% | 0.00% | 0.0% |
| Q1 2022 | $19,000 | -38.7% | 304 | -24.8% | 0.00% | 0.0% |
| Q4 2021 | $31,000 | -16.2% | 404 | +22.4% | 0.00% | 0.0% |
| Q3 2021 | $37,000 | -47.1% | 330 | -23.8% | 0.00% | -66.7% |
| Q2 2021 | $70,000 | +84.2% | 433 | +40.6% | 0.00% | +50.0% |
| Q1 2021 | $38,000 | 0.0% | 308 | +25.7% | 0.00% | 0.0% |
| Q4 2020 | $38,000 | +65.2% | 245 | -56.0% | 0.00% | 0.0% |
| Q1 2020 | $23,000 | +4.5% | 557 | +55.2% | 0.00% | 0.0% |
| Q4 2019 | $22,000 | +46.7% | 359 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | -11.8% | 359 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $17,000 | +54.5% | 359 | +79.5% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |